Cargando…

An Erk/Cdk5 axis controls the diabetogenic actions of PPARγ

Obesity-linked insulin resistance is a major precursor to the development of type 2 diabetes. Previous work has shown that phosphorylation of PPARγ at serine 273 by Cdk5 stimulates diabetogenic gene expression in adipose tissues(1). Inhibition of this modification is a key therapeutic mechanism for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banks, Alexander S., McAllister, Fiona E., Camporez, João Paulo G., Zushin, Peter-James H., Jurczak, Michael J., Laznik-Bogoslavski, Dina, Shulman, Gerald I., Gygi, Steven P., Spiegelman, Bruce M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297557/ https://www.ncbi.nlm.nih.gov/pubmed/25409143 http://dx.doi.org/10.1038/nature13887

Ejemplares similares

Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)

Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation
por: Choi, Jang Hyun, et al.
Publicado: (2011)

Lipopolysaccharide-induced inflammation in human peritoneal mesothelial cells is controlled by ERK1/2-CDK5-PPARγ axis
por: Li, Zukai, et al.
Publicado: (2021)

Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming
por: Choi, Jang Hyun, et al.
Publicado: (2014)

CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway
por: Bai, Xiaoyan, et al.
Publicado: (2016)

Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α Expression
por: Estall, Jennifer L., et al.
Publicado: (2009)

Diabetogene Umweltfaktoren
por: Wabnitz, Katharina, et al.
Publicado: (2022)

Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1
por: Chouchani, Edward T., et al.
Publicado: (2016)

Facultative protein selenation regulates redox sensitivity, adipose tissue thermogenesis, and obesity
por: Jedrychowski, Mark P., et al.
Publicado: (2020)

Cyclin D1-CDK4 Controls Glucose Metabolism Independently of Cell Cycle Progression
por: Lee, Yoonjin, et al.
Publicado: (2014)

Statin diabetogenicity: guidance for clinicians
por: Ray, Kausik
Publicado: (2013)

In Vivo Enrichment of Diabetogenic T Cells
por: Thelin, Martin A., et al.
Publicado: (2017)

Epigenetic regulation of diabetogenic adipose morphology
por: Kerr, A.G., et al.
Publicado: (2019)

Crocin Improves Insulin Sensitivity and Ameliorates Adiposity by Regulating AMPK-CDK5-PPARγ Signaling
por: Fang, Kai, et al.
Publicado: (2020)

Diabetogenic Potential of Ancestral and Modern Wheat Landraces
por: Aguayo-Patrón, Sandra V., et al.
Publicado: (2017)

Diabetogenic Effects of Ochratoxin A in Female Rats
por: Mor, Firdevs, et al.
Publicado: (2017)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

COMPARATIVE DIABETOGENIC ACTION OF THE HYPOPHYSIS FROM VARIOUS ANIMALS
por: Houssay, B. A., et al.
Publicado: (1942)

Diabetogenic Effect of Statins: A Double-Edged Sword?
por: Yoon, Ji Sung, et al.
Publicado: (2013)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Brève : Sars-CoV-2, agent diabétogène ?
por: Dalmat, Yann-Mickael
Publicado: (2021)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Phosphorylation of Beta-3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes
por: Hong, Shangyu, et al.
Publicado: (2018)

Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPARγ expression and phosphorylation
por: Wu, Ling, et al.
Publicado: (2010)

Fat feeding potentiates the diabetogenic effect of dexamethasone in Wistar rats
por: Sivabalan, Shanmugam, et al.
Publicado: (2008)

Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A
por: Delong, Thomas, et al.
Publicado: (2012)

Population attributable risks and costs of diabetogenic chemical exposures in the elderly
por: Trasande, Leonardo, et al.
Publicado: (2017)

Diabetogenically beneficial gut microbiota alterations in third trimester of pregnancy
por: Amabebe, Emmanuel, et al.
Publicado: (2021)

Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence
por: Kurşunoğlu, Niyazi Emre, et al.
Publicado: (2022)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality
por: Utreras, Elias, et al.
Publicado: (2014)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
por: Bolden, Adrienne, et al.
Publicado: (2012)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Dose Effect and Mode of Inheritance of Diabetogenic Gene on Mouse Chromosome 11
por: Babaya, Naru, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vusrkvk61qncace950vn6k6v7g